Schonfeld Strategic Advisors »

Silverback Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $265k 33k 8.03
2024-06-30 $231k 27k 8.51
2023-12-31 $90k 17k 5.48
2022-09-30 $62k 12k 5.34
2022-06-30 $86k 20k 4.22
2022-03-31 $100k 29k 3.51

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Rubric Capital Management
Deerfield Management Company
Millennium Management
BlackRock
Standard Life Aberdeen
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Vanguard Capital Management
UBS Group
Janney Montgomery Scott
Tyro Capital Management

View all funds holding Silverback Therapeutics